Sign in

You're signed outSign in or to get full access.

Trent Green

Trent Green

Chief Executive Officer at NATIONAL RESEARCH
CEO
Executive
Board

About Trent Green

Trent Green was appointed Chief Executive Officer and a director of NRC effective June 1, 2025, after more than 25 years of healthcare leadership, most recently as CEO of Amazon One Medical and previously as COO of Legacy Health . Age and education are not disclosed in the proxy. Company performance context prior to his tenure: 2024 net income was $24.8 million and revenue $143.1 million per the pay-versus-performance table .

Past Roles

OrganizationRoleYearsStrategic Impact
Amazon One MedicalChief Executive OfficerNot disclosedSenior leadership in primary care; cited by NRC as key experience for CEO role
Legacy HealthChief Operating OfficerNot disclosedLarge-system operations leadership; supports operational execution credentials

External Roles

OrganizationRoleYearsStrategic Impact
NRC Board of DirectorsDirector (executive)Effective June 1, 2025Board service concurrent with CEO role; Chairman becomes Michael Hays; Lead Independent Director remains John Nunnelly

Fixed Compensation

ComponentAmount/TermsSource
Annual Base Salary$1,250,000 (annualized)
Equity Grant500,000 “Green Shares” of Common Stock expected under 2025 Omnibus Plan; subject to repurchase and transfer restrictions (see details below)
Cash Signing BonusCash equal to the value of the Green Shares (based on closing price the trading day prior to Effective Date) multiplied by 66 2/3%

Performance Compensation

MetricWeightingTargetActualPayoutVesting
None disclosed for CEO package
Plan contextThe 2025 Omnibus Incentive Plan authorizes performance-based awards across a broad set of financial/strategic criteria for future grants

Equity Ownership & Alignment

ItemDetailsSource
Green Shares (Restricted Stock)500,000 shares; Company may repurchase for $1.00 if terminated for cause or resigns without good reason before the third anniversary of June 1, 2025; not transferable before third anniversary except with Company consent or to certain family/transfers; after third anniversary, only 50% of shares may be transferred during employment
Expected plan sourceShares expected to be issued under NRC’s 2025 Omnibus Incentive Plan approved May 7, 2025
Beneficial ownership listingNot listed among directors/executives as of the March 20, 2025 Record Date (pre-appointment)
Clawback policyCompany clawback covers Section 16 officers; recovery on restatement or misconduct, and breach of restrictive covenants
Hedging/pledgingCompany states it does not have practices or policies regarding employee/officer/director hedging; officers had not historically engaged in hedging as of the Record Date

Employment Terms

TermDetailsSource
Effective dateCEO and director effective June 1, 2025
SeveranceIf terminated without cause or resigns with good reason after the third anniversary of the Effective Date: one year of continued payment of then-current annual base salary
Change-in-controlNo change-in-control provision specified for Green’s equity in the proxy; plan-level terms exist generally for awards, but no specific CIC provision disclosed for Green Shares
Transfer/repurchaseCompany repurchase right ($1.00) prior to third anniversary upon cause/without good reason resignation; strict transfer limits through and after third anniversary as detailed above

Board Governance

  • Board independence: Five of six current directors are independent under NASDAQ standards (Berwick, Bhandari, Lockhart, Nunnelly, Wheeler) .
  • Leadership structure: Lead Independent Director is John Nunnelly; upon Green’s CEO appointment, Michael Hays transitions to Chairman .
  • Committees and Green’s roles: Audit (Chair Nunnelly), Compensation & Talent (Chair Lockhart), Nominating (Chair Berwick), Strategic Planning (Chair Nunnelly); Green is not listed on any committee and, as an executive director, is not independent .
  • Meeting cadence: Board held six meetings and one independent directors meeting in 2024; ≥75% attendance by all incumbents .

Director Compensation

ElementAmount/TermsSource
Executive directorsNo board compensation for executive officers serving as directors
Non-executive director fixed fee$75,000 annual fixed fee for Lead Director; $50,000 for each other director
Director Cash Payment (contingent)Up to $50,000 cash in two $25,000 increments, contingent on participation in two in-person meetings
Annual equity grant (non-employee)Option grant with target grant-date fair value ≈$100,000; vests immediately before next Annual Meeting; exercise price at fair market value on grant date

Say-on-Pay & Shareholder Feedback

Year/ProposalOutcomeSource
May 2024 say-on-payShareholders approved executive compensation with more than 98% of votes cast in favor
May 7, 2025 say-on-payVotes: For 20,655,974; Against 217,494; Abstain 182,633; Broker Non-Votes 829,100
May 7, 2025 Omnibus PlanApproved: For 16,852,672; Against 4,017,318; Abstain 186,111; Broker Non-Votes 829,100

Compensation Committee Analysis

  • Composition: Lockhart (Chair), Berwick, Bhandari, Nunnelly, Wheeler; all meet NASDAQ/SEC independence standards .
  • Consultants/peers: No compensation consultant engaged for 2024; company states absence of publicly traded peers and does not use a peer group .
  • Philosophy: Emphasis on aligning management with shareholders via equity grants and competitive pay for retention .

Compensation Structure Analysis

  • Shift to ownership alignment: Green’s package emphasizes large restricted stock ownership with stringent transfer/repurchase conditions, plus a formula-based signing bonus tied to market value—strong retention via illiquidity through year three and continued limitations thereafter .
  • Limited guaranteed pay escalation: Severance only after year three and limited to one year of base salary, with no disclosed bonus guarantees—moderate shareholder-friendly severance economics .
  • Performance linkage: No explicit performance metrics disclosed for Green’s initial package; future performance awards may be issued under the Omnibus Plan, which covers a broad set of financial and strategic criteria .
  • Governance safeguards: Plan prohibits option/SAR repricing without shareholder approval; fixed share pool; awards subject to clawback .

Risk Indicators & Red Flags

  • Hedging policy gap: Company reports no hedging policy for employees/officers/directors, which can weaken alignment and enable downside protection contrary to shareholder interests .
  • Related-party transactions: None in 2024; board policy requires Audit Committee review of any such transactions .
  • Dilution potential: Omnibus Plan authorizes up to 5,000,000 shares for awards (subject to adjustments), increasing flexibility but also potential dilution if heavily utilized .

Investment Implications

  • Strong retention lock-in via restricted stock: The three-year repurchase and transfer constraints plus ongoing 50% transfer cap during employment materially reduce near-term insider selling pressure while aligning Green’s wealth with stock performance; a positive for retention and long-term alignment .
  • Pay-for-performance watch: Absence of disclosed performance metrics in the CEO package raises a monitoring need for future grants under the Omnibus Plan to embed clear TSR/revenue/EBITDA drivers; shareholder-friendly safeguards exist at the plan level, but execution matters .
  • Governance quality: Independent committees, strong lead director structure, and high say-on-pay support credibility; executive director receives no board fees, limiting potential double-compensation concerns .
  • Trading signals: Expect limited near-term Form 4 selling from Green due to contractual transfer restrictions; reassess after the third anniversary when partial transferability begins. The Omnibus Plan approval broadens equity incentive capacity—track grant cadence and dilution versus burn-rate benchmarks disclosed by NRC .